Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


THE REGENTS OF THE UNIVERSITY OF CALIFORNIA THE OFFICE OF THE PRESIDENT

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA THE OFFICE OF THE PRESIDENT Patent applications
Patent application numberTitlePublished
20110263440COLORIMETRIC BIOASSAY FOR PERCHLORATE - The present invention relates to methods, compositions and systems for detecting perchlorate in a sample. Compositions useful for detecting perchlorate in a sample include those comprising a perchlorate reductase, a reductant and an electron shuttle. In an exemplary embodiment, the composition comprises perchlorate reductase from 10-27-2011
20110074422METHOD AND APPARATUS FOR MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY USING MULTIPLE-MODE COILS - A RF coil for use with a resonance imaging device, the RF coil comprises a conductor comprising a first conductive region, a second conductive region substantially isolated from the first portion along its length, and at least one coupling portion adjacent to ends of the first and second portions and configured to electrically couple the first and second portions at a first predetermined frequency. The coil further includes a dielectric substrate supporting the conductor. The RF coil is configured to perform one of excitation, detection, reception, or a combination thereof. A method of using one or more RF coil is further disclosed.03-31-2011
20100323957NOVEL ASSAY FOR INHIBITORS OF EGFR - The invention provides methods and compositions for screening for modulators of EGFR activity. In particular, an assay for such modulators is provided, which includes methods of screening for modulators using models of the three dimensional structure of EGFR kinase domains.12-23-2010
20100120678NOVEL INHIBITORS OF THE EGFR KINASE TARGETING THE ASYMMETRIC ACTIVATING DIMER INTERFACE - The invention provides methods and compositions for the modulation of EGFR activity, in particular, inhibition of EGFR activation through an allosteric mechanism is discloses, as is a method for targeted drug discovery and design based on models of the three dimensional structure of the kinase domains of the protein dimers.05-13-2010

Patent applications by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA THE OFFICE OF THE PRESIDENT